US 11919937
T cell receptors for immunotherapy
granted A61KA61K2239/38A61K2239/48
Quick answer
US patent 11919937 (T cell receptors for immunotherapy) held by The Board of Regents of the University of Texas System expires Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Mar 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2239/38, A61K2239/48, A61K31/675, A61K31/7076